CHEK2 GENE MUTATION
Clinical trials for CHEK2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new CHEK2 GENE MUTATION trials appear
Sign up with your email to follow new studies for CHEK2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope pill targets weakness in advanced breast cancer
Disease control OngoingThis study is testing whether a pill called olaparib can help control metastatic breast cancer that has spread in the body. It is for patients whose cancer has a specific weakness—a mutation in certain genes that help repair damaged DNA. The goal is to see if targeting this weakn…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Targeted prostate cancer trial for hispanic and black men withdrawn before start
Disease control TerminatedThis study aimed to test a combination of two drugs, niraparib and abiraterone, plus a steroid, in men with newly diagnosed, advanced prostate cancer that had spread and had specific genetic changes. It specifically sought Hispanic/Latino and non-Hispanic Black participants to se…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC